26 related articles for article (PubMed ID: 11504090)
1. Effective method of measuring the radioactivity of [ 131I]-capsule prior to radioiodine therapy with significant reduction of the radiation exposure to the medical staff.
Lützen U; Zhao Y; Marx M; Imme T; Assam I; Siebert FA; Culman J; Zuhayra M
J Appl Clin Med Phys; 2016 Jul; 17(4):59-72. PubMed ID: 27455475
[TBL] [Abstract][Full Text] [Related]
2. Antibody therapy of non-Hodgkin's B-cell lymphoma.
Chinn P; Braslawsky G; White C; Hanna N
Cancer Immunol Immunother; 2003 May; 52(5):257-80. PubMed ID: 12700943
[TBL] [Abstract][Full Text] [Related]
3. Safe radiation exposure of medical personnel by using simple methods of radioprotection while administering 131I-lipiodol therapy for hepatocellular carcinoma.
Garin E; Laffont S; Rolland Y; Olivie D; Lecloirec J; Herry JY; Boucher E; Raoul JL; Bourguet P
Nucl Med Commun; 2003 Jun; 24(6):671-8. PubMed ID: 12766603
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial radionuclide therapy for liver tumours: effect of selectivity of catheterization and 131I-Lipiodol delivery on tumour uptake and response.
Brans B; Bacher K; Vandevyver V; Vanlangenhove P; Smeets P; Thierens H; Dierckx RA; Defreyne L
Nucl Med Commun; 2003 Apr; 24(4):391-6. PubMed ID: 12673167
[TBL] [Abstract][Full Text] [Related]
5. Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma.
Bhattacharya S; Novell JR; Dusheiko GM; Hilson AJ; Dick R; Hobbs KE
Cancer; 1995 Dec; 76(11):2202-10. PubMed ID: 8635022
[TBL] [Abstract][Full Text] [Related]
6. Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol (Br J Surg 2003; 90: 1379-1383).
Rai R; Rai S
Br J Surg; 2004 Mar; 91(3):373; author reply 373. PubMed ID: 14991642
[No Abstract] [Full Text] [Related]
7. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.
Leung WT; Lau WY; Ho S; Chan M; Leung N; Lin J; Ho KC; Metreweli C; Johnson PJ; Li AK
J Nucl Med; 1994 Aug; 35(8):1313-8. PubMed ID: 7519259
[TBL] [Abstract][Full Text] [Related]
8. Radiation exposure and radiation protection of the physician in iodine-131 Lipiodol therapy of liver tumours.
Risse JH; Ponath C; Palmedo H; Menzel C; Grünwald F; Biersack HJ
Eur J Nucl Med; 2001 Jul; 28(7):914-8. PubMed ID: 11504090
[TBL] [Abstract][Full Text] [Related]
9. Radioiodine therapy: care of the helpless patient and handling of the radioactive corpse.
Greaves C; Tindale W
J Radiol Prot; 2001 Dec; 21(4):381-92. PubMed ID: 11787894
[TBL] [Abstract][Full Text] [Related]
10. Therapy of hepatocellular cancer with iodine-131-Lipiodol.
Risse JH; Menzel C; Grünwald F; Strunk H; Biersack HJ; Palmedo H
Rom J Gastroenterol; 2004 Jun; 13(2):119-24. PubMed ID: 15229776
[TBL] [Abstract][Full Text] [Related]
11. Treatment of unresectable hepatocellular carcinoma: targeted therapies using iodized oil.
Bhattacharya S; Dusheiko GM
Princess Takamatsu Symp; 1995; 25():253-64. PubMed ID: 8875631
[TBL] [Abstract][Full Text] [Related]
12. 131-iodine Lipiodol therapy in hepatocellular carcinoma.
Raoul JL; Boucher E; Roland V; Garin E
Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):348-55. PubMed ID: 19521315
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]